Cardiorenal effects of nonsteroidal MRAs in patients with CKD and T2DM
10' education - June 7, 2022 - Eugene E. Wright, Jr., MD (Charlotte, NC, USA), Jolanta Małyszko, MD, PhD (Warsaw, Poland) and María José Soler, MD, PhD (Barcelona, Spain)Educational information
This video was distributed by our partner, ReachMD, a leading online learning platform for physicians and other healthcare professionals.
Faculty
- Eugene E. Wright, Jr., MD, Medical Director, Charlotte Area Health Education Center, Charlotte, NC, USA
- Jolanta Małyszko, MD, PhD - Professor at the department of Nephrology, dialysis and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
- María José Soler, MD, PhD - nephrologist, Vall d'Hebron University Hospital, Barcelona, Spain
Disclosures
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of PACE-cme.
Funding
This activity is supported by an independent educational grant from Bayer.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: